The Brazilian skincare market has great potential for anti-acne products. According to the Brazilian Society of Dermatology, acne is one of the most common skin problems, affecting approximately 80% of the population at some point in their lives.
Caused by obstruction of the sebaceous glands, the inflammatory disease can be caused by several factors, such as the accumulation of bacteria, hormonal dysregulation and, especially, excess oil. “Brazil’s tropical climate and environmental conditions contribute to the prevalence of oily skin prone to acne and blemishes.”, he states Bruna Pessuto, director of marketing for dermatological skincare and therapeutic dermatology at Galderma.
With Cetaphil, the company launched Oil Control, the brand’s first line for the care of this type of skin. “We carefully consider the specific needs of the Brazilian consumer, so much so that the line is produced locally, at the Galderma global unit in Hortolândia (SP)”, says Pessuto. With items such as Deep Cleansing Soap and Matifying Anti-Blemish Moisturizer, Oil Control aims to combat oiliness, but also protects the skin barrier and contributes to improving acne spots and texture in general, using renowned skincare ingredients, such as acid salicylic, niacinamide and panthenol.
Bioactive extracted from a plant that develops after forest fires
The personal care division of BASF bet on a new bioactive for the care of oily skin prone to acne spots, the Epispot. “It has a triple mechanism of action, balancing skin lipids, reducing the number of active sebocytes and total lipid production, which results in a mattifying effect that prevents excessive shine.”, points out the marketing analyst for personal care Nathalia Tavana.
She explains that the ingredient, extracted from the Epilobium angustifolium plant (known as fire grass or phoenix flower because it develops after forest fires and logging operations), controls the virulence of microorganisms such as Staphylococcus aureus It is Cutibacterium acnes, reducing the inflammatory process that leads to spots. “Epispot also regulates hyperkeratinization, preventing the formation of enlarged pores, and protects sebum against oxidation, maintaining its quality”.
Tavana says that the growing supply of anti-acne cosmetics in the Brazilian market can be attributed to changing consumer behavior, influenced by the dominance of skincare on social media, and the early interest in skin care among the alpha generation. “This generation must have the greatest purchasing power in history and has been shaping trends in the cosmetics market. This is also reflected in the search for acne care, as it is a very prevalent skin condition among younger consumers.”.
Routine care for acne-prone skin has gained several steps
On the market for 20 years, the Actine line has become the most prescribed by dermatologists in Brazil for acne care. Produced by Darrow Laboratorythe Brazilian brand of Pierre Fabre Group followed developments in this segment. “In recent decades, we have seen significant advances in the cosmetics industry for the treatment of acne and in the way Brazilian consumers deal with this issue. A routine that, 20 years ago, was quite simple, normally limited to a bar of soap, today includes several steps”, he states Flavianne Baptista, marketing director at Laboratoires Pierre Fabre in Brazil.
One of these steps, hydration, was included in the recent Aquaforce launch. “It is a mistaken idea to think that oily skin does not need hydration. In fact, the use of adequate moisturizers is essential to maintain skin health and minimize the side effects that frequently occur during skin treatments. acne”explains the medical director Ana Coutinho. With a super-light gel texture, the product promises hydration for 48 hours and immediate absorption.
“Brazilians are more informed about skin care and are looking for increasingly effective and personalized solutions for their acne problems. In turn, cosmetics companies are responding to this growing demand by investing in new technologies, research and development of innovative and clinically proven products.”, concludes Baptista.
